Odit Gutwein

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

<scp>BNT162b2 COVID</scp>‐19 vaccine is significantly less effective in patients with hematologic malignancies

Katrin Herzog Tzarfati, Odit Gutwein, Arie Apel et al. · American Journal of Hematology · 2021 · 167 citations · Full text

Veterinary Medicine, Hematology, Immunology +17

Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype

Katia Beider, Hanna Bitner, Merav Leiba et al. · Oncotarget · 2014 · 165 citations · Full text

Medicine, Hematology, Immunology +17

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14

GPRC5D is a promising marker for monitoring the tumor load and to target multiple myeloma cells

Yossi Cohen, Odit Gutwein, Osnat Garach‐Jehoshua et al. · Hematology · 2013 · 51 citations

Medicine, Molecular Biology, Oncology +16